Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents (Rameda) S.A.E.

CASE:RMDA Stock Report

Market Cap: ج.م5.0b

Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents (Rameda)E Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

What is the ownership structure of RMDA?
Owner TypeNumber of SharesOwnership Percentage
Individual Insiders46,397,4033.09%
Institutions175,113,86011.6%
Private Companies601,045,84040%
General Public680,907,82945.3%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Top 11 shareholders own 54.71% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
18.7%
Equinox Pharma Holding Ltd.
281,089,314ج.م941.6m0%no data
11.2%
The Saudi Seventh Investment Company
167,704,795ج.م561.8m0%no data
10.1%
Ekuity B.V.
152,251,731ج.م510.0m0%no data
7.02%
Blominvest Bank, Asset Management Arm
105,546,872ج.م353.6m4.06%no data
3.11%
Russell Investment Management, LLC
46,729,000ج.م156.5m0%no data
2.23%
Amr Morsy
33,502,289ج.م112.2m19.5%no data
1.52%
Sanlam Investment Management (Pty) Ltd.
22,837,988ج.م76.5m0%0.02%
0.62%
Ahmed Mohammed Issameddin Mohammed Fahmi
9,263,500ج.م31.0m0%no data
0.24%
Mahmoud Mustafa Salaheddine Fayek
3,615,767ج.م12.1m50.8%no data
0.00053%
Ayman Mamdouh Mohamed Abbas
7,924ج.م26.7k0%no data
0.00053%
Shamel Aboul Fadl
7,923ج.م26.7k0%no data